Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - IBERE PHARMACEUTICALS | tm2123990d1_8k.htm |
Exhibit 16.1
August 4, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Ibere Pharmaceuticals under Item 4.01 of its Form 8-K dated August 4, 2021. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Ibere Pharmaceuticals contained therein.
Very truly yours,
/s/ Marcum LLP
Marcum LLP